Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (57 ops.)
Latest filing published 23 Mar 2026 for Biolife Solutions INC, €16k. Read the official filing
Filing timeline
BuySaleSarah Aebersold
Insider track record
Disclosed buys
0
Disclosed sells
57
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sarah Aebersold: trading record in brief
Sarah Aebersold is a declared insider of Biolife Solutions Inc (senior executive), with filings sourced from SEC (Form 4). The record holds 65 filings, for trades running from 20 July 2021 to 19 March 2026.
Every open-market trade on record is a sale: 57 sales worth €901k. Outside the open market, there are 7 share grants and 1 option exercise. 2026 to date brings no purchases and 2 sales.
On 23 March 2026 came the latest disclosure, a share grant for €16k in Biolife Solutions Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sarah Aebersold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations65 total
931 shares@ US$19.121.8% of flowCommon StockSEC:0001628280-26-020577:0
219 shares@ US$20.740.4% of flowCommon StockSEC:0001628280-26-015337:0
23,548 sharesCommon StockSEC:0001628280-26-012472:0
241 shares@ US$25.590.6% of flowCommon StockSEC:0001628280-26-001384:0
233 shares@ US$25.130.6% of flowCommon StockSEC:0001628280-25-057722:0
217 shares@ US$26.740.6% of flowCommon StockSEC:0001628280-25-054281:0
188 shares@ US$27.360.5% of flowCommon StockSEC:0001628280-25-045016:0
714 shares@ US$25.611.7% of flowCommon StockSEC:0001837756-25-000005:0
233 shares@ US$26.830.6% of flowCommon StockSEC:0001837756-25-000003:0
219 shares@ US$25.440.5% of flowCommon StockSEC:0001628280-25-041300:0
198 shares@ US$22.270.4% of flowCommon StockSEC:0001628280-25-034685:0
711 shares@ US$22.231.6% of flowCommon StockSEC:0001628280-25-032190:0
235 shares@ US$23.700.6% of flowCommon StockSEC:0001628280-25-031099:0
217 shares@ US$22.460.5% of flowCommon StockSEC:0001628280-25-028707:0
210 shares@ US$20.110.4% of flowCommon StockSEC:0001628280-25-017587:0
5,771 shares@ US$22.6613.6% of flowCommon StockSEC:0001628280-25-016637:0
2,695 shares@ US$25.447.1% of flowCommon StockSEC:0001628280-25-014185:0
15,279 sharesCommon StockSEC:0001628280-25-014194:0
5,632 shares@ US$24.9614.5% of flowCommon StockSEC:0001628280-25-013585:0
2,695 shares@ US$25.447.1% of flowCommon StockSEC:0001628280-25-013585:1
1,091 shares@ US$25.002.8% of flowCommon StockSEC:0001628280-25-012680:0
284 shares@ US$25.460.8% of flowCommon StockSEC:0001628280-25-010563:0
53 shares@ US$26.540.2% of flowCommon StockSEC:0001628280-25-005839:0
240 shares@ US$27.020.7% of flowCommon StockSEC:0001628280-25-000987:0
216 shares@ US$27.200.6% of flowCommon StockSEC:0001628280-24-049477:0
25 of 65 declarations
